Shenzhen, China – BGI-Shenzhen (“BGI”) announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the “Offer”) to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: GNOM) (“Complete”) to 12:00 midnight (New York City time) on Wednesday, February 6, 2013. The Offer was […]
Madison, WI, USA and Penzberg, Germany — Roche announced today the global launch and availability of a new comprehensive suite of SeqCap EZ Reagent kits for application in single or multiplex target enrichment experiments prior to DNA Sequencing. Designed to maximize customer convenience and streamline the DNA preparation workflow, the new kits provide customers with […]
CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ: LIFE) today announced the establishment of the Global Influenza Network, a partnership including scientists at a number of the world’s leading government public health organizations, veterinary agencies and research institutes in a collaborative effort to increase the speed and efficiency of influenza monitoring and vaccine development. Members of […]
MENLO PARK, Calif., — Pacific Biosciences of California, Inc. (Nasdaq:PACB) provider of the PacBio(R) RS High Resolution Genetic Analyzer, today announced it is releasing a new software upgrade that provides higher quality genome assemblies with near perfect base level accuracy in addition to other key features. The software upgrade extends the range of projects that […]
Santa Barbara, Calif.–– New equipment at UC Santa Barbara is helping the university to do what it does best –– collaborate across disciplines. In this case, biologists are working with computer scientists to understand the human genome. The effort is expected to develop into a full-fledged genomics center. The campus has acquired a new gene […]
Shenzhen, China—BGI-Shenzhen (“BGI”) announced today that it, through its wholly-owned subsidiary Beta Acquisition Corporation, has extended its all cash tender offer (the “Offer”) to purchase all outstanding shares of common stock of Complete Genomics, Inc. (NASDAQ: GNOM) (“Complete”) to 12:00 midnight (New York City time) on Friday, January 25, 2013. The Offer was previously scheduled […]
CARLSBAD, Calif., — The board of directors of Life Technologies Corporation has retained Deutsche Bank Securities Inc. and Moelis & Company LLC to assist in its annual strategic review. The board of directors has not decided on any specific course of action. About Life Technologies Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company […]
IMGM Laboratories, a genomic service provider based in Martinsried/Munich, has recently upgraded its next generation sequencing-based Metagenomics services. Metagenomics – the study of genomic content in a complex mixture of microorganisms – is a currently very active field. With a fleet of Roche 454 instruments and specialized know-how, IMGM generates high information content data sets […]
Using a Uniqsis FlowSyn™ flow reactor system – Sygnature Discovery (Nottingham, UK), a leading provider of integrated drug discovery services to the pharmaceutical industry, has reported results demonstrating how the system allows them to perform traditionally hazardous chemistries in a controlled manner. For example, using the proprietary FlowSyn technology with a Uniqsis GAM IIgas-liquid reactor, […]
FREMONT, Calif., — WaferGen Bio-systems, Inc. (OTCBB: WGBS) today announced the successful completion of a proof-of-concept study using its newly-developed proprietary nano-qPCR technology for sample preparation prior to targeted re-sequencing on Next-Gen platforms. The results can be viewed in white paper form at: Target enrichment with uniform coverage approaching 100% is difficult to achieve with […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
